Gerard Scardino, MD
NPI 1619087111 · Psychiatry Physician · Houston, TX
Enrolled with Medicare as Practitioner - Psychiatry · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1619087111
- Entity type
- Individual
- Primary specialty
- Psychiatry PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- H1207 (TX)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
19 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
999 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 538 | $127 |
| Psychotherapy, 45 Minutes90834 | 274 | $103 |
| Psychotherapy, 30 Minutes90832 | 54 | $78 |
| Psychiatric Diagnostic Evaluation With Medical Services90792 | 23 | $194 |
| Measurement of Brain Wave Activity (eeg), Awake and Drowsy95816 | 21 | $390 |
| Evaluation of Neuropsychological Test, First Hour96132 | 16 | $128 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 58 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Alprazolam | 404 | 74 |
| Quetiapine Fumarate | 297 | 36 |
| Dextroamphetamine/Amphetaminebrand: Dextroamphetamine-Amphetamine | 269 | 37 |
| Bupropion Hclbrand: Bupropion Xl | 254 | 23 |
| Mirtazapine | 217 | 26 |
| Escitalopram Oxalate | 201 | 32 |
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-08-30
- Last updated
- 2008-08-20
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.